Sung Won Song
Director/Board Member at JW (CAYMAN) THERAPEUTICS CO. LTD
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chen Bing Wu | M | - |
EpimAb Biotherapeutics, Inc.
 EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | 8 years |
| Yi Ping Li | M | 59 | 7 years | |
| Nilda Mesa | F | 64 |
The Trustees of Columbia University in The City of New York
| 16 years |
| Debra Yu | M | 59 | 1 years | |
| Yiu Leung Cheung | M | 64 | 4 years | |
| Krishna Viswanadhan | - | - | 5 years | |
| Ann Li Lee | M | 63 | 4 years | |
| Krishnan Viswanadhan | M | 45 | 5 years | |
| Kin Cheong Ho | M | 56 | 4 years | |
| Patrice Le Melle | F | 65 |
The Trustees of Columbia University in The City of New York
| 16 years |
| Hong Xia Zheng | M | 55 | 5 years | |
| Ya Jun Xu | M | - |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | - |
| Xing Gao | F | 39 | 4 years | |
| Stephan Lensky | M | - |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | - |
| Sang Min Choi | M | - |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | - |
| Dong Fang Li | M | - |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | - |
| Cheng Xing | M | - |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | - |
| Raymond Joseph Hage | M | 56 | 2 years | |
| Ho In | M | 57 |
Korea University
| 21 years |
| Sung-Wook Nam | M | 65 |
Korea University
| 22 years |
| Jun An Lu | M | 35 |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | - |
| Ka Man Ng | F | - | 3 years | |
| Mark Gilbert | M | 63 | - | |
| Hee-Cheon Kim | M | 63 |
Korea University
| 21 years |
| Kyeong-Heon Kim | M | 63 |
Korea University
| 21 years |
| Jong-Heun Lee | M | 58 |
Korea University
| 21 years |
| Victor Tong | M | 41 |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | - |
| Qun Zhao | M | - |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | - |
| Cheng Liu | M | 57 | 4 years | |
| Robert Kamen | M | 79 |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | 9 years |
| Erik Engelson | M | 64 |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | 10 years |
| Cheryl Turnbull | F | 63 |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | 11 years |
| Shaun Paul Cordoba | M | 43 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Schottenstein | M | 71 |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | 9 years |
| Sankesh Abbhi | M | 38 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Anish Monga | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Xin Yi Dong | M | 48 |
Korea University
| 6 years |
| Liz Beerman | F | - |
The Trustees of Columbia University in The City of New York
| 14 years |
| Sebastian Rondeau | M | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Xin Yi Dong | M | 47 |
Korea University
| 6 years |
| Siddarth Subramony | M | 37 |
The Trustees of Columbia University in The City of New York
| 5 years |
| Waheed Ahmad Sheikh | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Wen Yu Yang | F | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Mindy Lau | F | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Jeremy Colvin | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Cem Oztreves | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Craig Murray Sarembock | M | 46 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Jong-Kil Lim | M | 56 |
Korea University
| 2 years |
| Lauren McCarthy | F | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Brad Doppelt | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Chawkat Nammour | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Laura Spiekerman | F | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Samer Samman | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Michael Chan | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| João Moreira Salles | M | 43 |
The Trustees of Columbia University in The City of New York
| 1 years |
| Riham Tawfiq Ismael Hussein | F | 46 |
The Trustees of Columbia University in The City of New York
| 1 years |
| Andrew Barza | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Julia Jiang | F | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Murphy Caine | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Megan Johnston Rand | F | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Samuel Cecil | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Robert Hauschildt | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Aisha Salahuddin | F | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Jeremy Y Xia | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Stone Kevin | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Libby Hauser | F | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Jason A. Bauer | M | 45 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Charles Maurice Stam | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| David D. Lee | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Adrian N. Almazan | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Mark Astrachan | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Eugene Wu | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Wolf Joffe | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Bobby Geornas | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Corey B. McKiernan | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Zachary Sadow | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Chris Meredith | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Andre Benjamin | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Greg Kuczynski | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Theodore H. Wagenknecht | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Martin Lehr | M | 40 |
The Trustees of Columbia University in The City of New York
| 1 years |
| Siming Yang | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| David Rogovic | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Alexander Busse | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| David Michael Kessler | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Wei Wei Hsing | F | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Renzo Merino | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Alex Giron Gordillo | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Laurent Vasilescu | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Eric Gonzalez | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Nitin Kumar | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Teresa Fazio | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Ariane Ortiz-Bollin | F | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Sunney Newsome | F | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Bryant Dieffenbacher | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Jeffrey Stroll | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Angela Wang | F | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Ryan Sutherland | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Peter Kalmus | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 66 | 66.67% |
| China | 25 | 25.25% |
| South Korea | 8 | 8.08% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sung Won Song
- Personal Network
